Opioid

Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019

Feb 18, 2021 | Julia Zigman

A new CDC report demonstrates significant increases in deaths involving synthetic opioids other than methadone, cocaine, and psychostimulants in recent years. A staggering total of 70,630 drug overdose deaths occurred in the United States in 2019.

From 2013 to 2019, the age-adjusted rate of deaths involving synthetic opioids other than methadone increased 1,040%, and for psychostimulants increased 317%. During 2018–2019, the largest relative increase in synthetic opioid-involved death rates occurred in the West (67.9%), and the largest relative increase in psychostimulant-involved death rates occurred in the Northeast (43.8%).

The data shows that evidence-based prevention and response strategies, including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use, must be adapted to address the changing drug overdose epidemic.

Read the full MMWR report here.


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

Related Posts

Cdc badge small
  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Injury and Violence Prevention

Overdose Deaths Accelerating During COVID-19

Over 81,000 drug overdose deaths occurred in the United States in the 12 months...

Jan 06, 2021 | Julia Zigman

Overdose Deaths Accelerating During COVID-19

NACCHO color pms321
  • Press Release
  • Opioid Overdose Epidemic

NACCHO Awards New Overdose Response Project Funding

NACCHO Awards New Overdose Response Project Funding; Public Health Projects in...

Jan 27, 2021 | Andrea Grenadier

NACCHO Awards New Overdose Response Project Funding

Back to Top